Search results
•NICE guideline (DG23) PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor/BRAHMS PlGF plus Kryptor PE ratio).
25 cze 2019 · This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension.
25 cze 2019 · Advise women who have had pre-eclampsia to achieve and keep a BMI within the healthy range before their next pregnancy (18.5 to 24.9 kg/m 2). See also the NICE guideline on obesity. [2010, amended 2019]
25 cze 2019 · Recommendations for research. As part of the 2019 update, the guideline committee made 6 research recommendations on the management of pregnancy with chronic hypertension, pre-eclampsia, fetal monitoring, the use of antihypertensives in breastfeeding and advice and follow-up.
OVERVIEW. Aims to predict the risk of MATERNAL (no baby!!) adverse outcomes at 48 hours (PREP-S) and by discharge (PREP-L) in EARLY ONSET PRE-. ECLAMPSIA (up to 34/40) Model developed in UK, validated in multi-national and Netherlands cohorts.
Women who develop severe pre-eclampsia and eclampsia. The guidance encompasses the principles within the NICE clinical guidance (NG133) hypertension in pregnancy: diagnosis and management, and NICE Quality Standard number 35 hypertension in pregnancy.
The recommendations on management of women at high risk of, or exhibiting clincical featues of pre-eclampsia are largely based on expert opinion in the National Institute of Health and Care Excellence (NICE) guideline Hypertension in pregnancy: diagnosis and management [NICE, 2019b].